| 000 | 00687nam a22001937a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20230524111457.0 | ||
| 008 | 230524b |||||||| |||| 00| 0 eng d | ||
| 082 |
_222 _a616.462061 _bN19I |
||
| 100 |
_aNath, Virendra _eResearcher |
||
| 245 |
_aIn silico studies and synthesis of novel heterocyclic compounds as agonist/antagonist for targets involved in type-2 diabetes mellitus _cby Virendra Nath; guided by Vipin Kumar |
||
| 260 | _c2022 | ||
| 300 |
_axvii, 302p. _bHardback |
||
| 500 | _aAnnexure I (i to lii) and Annexure II (liii to lvii) at the end. | ||
| 653 | _aDrug Design | ||
| 653 | _aDiabetes Mellitus | ||
| 700 |
_aKumar, Vipin _eGuide |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c26190 _d26190 |
||